Business Description
Hims & Hers Health Inc
NAICS : 811490
SIC : 2844
ISIN : US4330001060
Description
Financial Strength
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 22.37 | |||||
Equity-to-Asset | 0.73 | |||||
Debt-to-Equity | 0.03 | |||||
Debt-to-EBITDA | 0.2 | |||||
Interest Coverage | N/A | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 28.11 | |||||
Beneish M-Score | -3 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 37.8 | |||||
3-Year EPS without NRI Growth Rate | 37.3 | |||||
Future 3-5Y Total Revenue Growth Rate | 39.07 |
Momentum Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 77.07 | |||||
9-Day RSI | 70.08 | |||||
14-Day RSI | 66.64 | |||||
6-1 Month Momentum % | 13.59 | |||||
12-1 Month Momentum % | 155.34 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.14 | |||||
Quick Ratio | 1.82 | |||||
Cash Ratio | 1.66 | |||||
Days Inventory | 51.08 | |||||
Days Sales Outstanding | 1.56 | |||||
Days Payable | 81.47 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -4 | |||||
Shareholder Yield % | 1.02 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 81.13 | |||||
Operating Margin % | 3.46 | |||||
Net Margin % | 8.15 | |||||
FCF Margin % | 12.05 | |||||
ROE % | 27.83 | |||||
ROA % | 21.22 | |||||
ROIC % | 38.76 | |||||
ROC (Joel Greenblatt) % | 82.99 | |||||
ROCE % | 11.53 |
GF Value Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 73.23 | |||||
Forward PE Ratio | 64.84 | |||||
PE Ratio without NRI | 73.23 | |||||
Price-to-Owner-Earnings | 52.05 | |||||
PS Ratio | 5.93 | |||||
PB Ratio | 15.95 | |||||
Price-to-Tangible-Book | 24.78 | |||||
Price-to-Free-Cash-Flow | 50.03 | |||||
Price-to-Operating-Cash-Flow | 39.88 | |||||
EV-to-EBIT | 158.41 | |||||
EV-to-Forward-EBIT | 155.63 | |||||
EV-to-EBITDA | 120.1 | |||||
EV-to-Forward-EBITDA | 23.79 | |||||
EV-to-Revenue | 5.47 | |||||
EV-to-Forward-Revenue | 3.19 | |||||
EV-to-FCF | 45.43 | |||||
Price-to-Graham-Number | 9 | |||||
Price-to-Net-Current-Asset-Value | 42.96 | |||||
Price-to-Net-Cash | 76.71 | |||||
Earnings Yield (Greenblatt) % | 0.63 | |||||
FCF Yield % | 2.13 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NYSE:HIMS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Hims & Hers Health Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 1,241.994 | ||
EPS (TTM) ($) | 0.44 | ||
Beta | 2.12 | ||
Volatility % | 106.61 | ||
14-Day RSI | 66.64 | ||
14-Day ATR ($) | 2.962199 | ||
20-Day SMA ($) | 24.7465 | ||
12-1 Month Momentum % | 155.34 | ||
52-Week Range ($) | 8.09 - 35.02 | ||
Shares Outstanding (Mil) | 218.48 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Hims & Hers Health Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Hims & Hers Health Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Hims & Hers Health Inc Frequently Asked Questions
What is Hims & Hers Health Inc(HIMS)'s stock price today?
When is next earnings date of Hims & Hers Health Inc(HIMS)?
Does Hims & Hers Health Inc(HIMS) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |